Search research articles
Contact Us
Filters
Showing results (491-500 of 594) with videos related to
Page
of 60
Sort By:
Cancers
|
May 14, 2025
Lung Cancer Risk Prediction in Patients with Persistent Pulmonary Nodules Using the Brock Model and Sybil Model
Hui Li, Morteza Salehjahromi, Myrna C B Godoy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 10, 2020
Impact of Neoadjuvant Durvalumab with or without Tremelimumab on CD8<sup>+</sup> Tumor Lymphocyte Density, Safety, and Efficacy in Patients with Oropharynx Cancer: CIAO Trial Results
Renata Ferrarotto, Diana Bell, Maria L Rubin, et al.
Cancer
|
July 19, 2002
The novel and effective nonplatinum, nontaxane combination of gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma: potential for decreased toxicity and combination with biological therapy
Roy S Herbst, Fadlo R Khuri, Charles Lu, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 20, 2012
Redesigning radiotherapy quality assurance: opportunities to develop an efficient, evidence-based system to support clinical trials--report of the National Cancer Institute Work Group on Radiotherapy Quality Assurance
Justin E Bekelman, James A Deye, Bhadrasain Vikram, et al.
Molecular Cancer Therapeutics
|
June 10, 2010
Serum signature of hypoxia-regulated factors is associated with progression after induction therapy in head and neck squamous cell cancer
Lauren Averett Byers, F Christopher Holsinger, Merrill S Kies, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
February 8, 2018
Multiregion gene expression profiling reveals heterogeneity in molecular subtypes and immunotherapy response signatures in lung cancer
Won-Chul Lee, Lixia Diao, Jing Wang, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
September 6, 2015
New DNA methylation markers and global DNA hypomethylation are associated with oral cancer development
Jean-Philippe Foy, Curtis R Pickering, Vassiliki A Papadimitrakopoulou, et al.
Nature Communications
|
January 31, 2019
Author Correction: Circulating tumor DNA analysis depicts subclonal architecture and genomic evolution of small cell lung cancer
Jingying Nong, Yuhua Gong, Yanfang Guan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 9, 2019
Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study
Daniel R Gomez, Chad Tang, Jianjun Zhang, et al.
JCO Precision Oncology
|
January 30, 2023
Benchmarking Outcomes for Molecularly Characterized Synchronous Oligometastatic Non-Small-Cell Lung Cancer Reveals <i>EGFR</i> Mutations to Be Associated With Longer Overall Survival
Brian De, Ahsan S Farooqi, Kyle G Mitchell, et al.
Page
of 60
Search research articles
Search
Showing results (491-500 of 594) with videos related to
Sort By:
Page
of 60
Cancers
|
May 14, 2025
Lung Cancer Risk Prediction in Patients with Persistent Pulmonary Nodules Using the Brock Model and Sybil Model
Hui Li, Morteza Salehjahromi, Myrna C B Godoy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 10, 2020
Impact of Neoadjuvant Durvalumab with or without Tremelimumab on CD8<sup>+</sup> Tumor Lymphocyte Density, Safety, and Efficacy in Patients with Oropharynx Cancer: CIAO Trial Results
Renata Ferrarotto, Diana Bell, Maria L Rubin, et al.
Cancer
|
July 19, 2002
The novel and effective nonplatinum, nontaxane combination of gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma: potential for decreased toxicity and combination with biological therapy
Roy S Herbst, Fadlo R Khuri, Charles Lu, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 20, 2012
Redesigning radiotherapy quality assurance: opportunities to develop an efficient, evidence-based system to support clinical trials--report of the National Cancer Institute Work Group on Radiotherapy Quality Assurance
Justin E Bekelman, James A Deye, Bhadrasain Vikram, et al.
Molecular Cancer Therapeutics
|
June 10, 2010
Serum signature of hypoxia-regulated factors is associated with progression after induction therapy in head and neck squamous cell cancer
Lauren Averett Byers, F Christopher Holsinger, Merrill S Kies, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
February 8, 2018
Multiregion gene expression profiling reveals heterogeneity in molecular subtypes and immunotherapy response signatures in lung cancer
Won-Chul Lee, Lixia Diao, Jing Wang, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
September 6, 2015
New DNA methylation markers and global DNA hypomethylation are associated with oral cancer development
Jean-Philippe Foy, Curtis R Pickering, Vassiliki A Papadimitrakopoulou, et al.
Nature Communications
|
January 31, 2019
Author Correction: Circulating tumor DNA analysis depicts subclonal architecture and genomic evolution of small cell lung cancer
Jingying Nong, Yuhua Gong, Yanfang Guan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 9, 2019
Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study
Daniel R Gomez, Chad Tang, Jianjun Zhang, et al.
JCO Precision Oncology
|
January 30, 2023
Benchmarking Outcomes for Molecularly Characterized Synchronous Oligometastatic Non-Small-Cell Lung Cancer Reveals <i>EGFR</i> Mutations to Be Associated With Longer Overall Survival
Brian De, Ahsan S Farooqi, Kyle G Mitchell, et al.
Page
of 60